Cheryl Dambrot

Cheryl Dambrot received her PhD from Leiden University with research in the field of stem cell biology, focusing on generating induced pluripotent stem cells to model cardiac disease. She performed her post-doctoral study at the Yale Stem Cell Center, where she investigated the mechanism behind mouse and human cellular reprogramming.

At Cergentis, Cheryl works as part of the service projects team performing TLA and data analysis for our customers.